3D Systems Corporation Announces Strategic Organizational Changes and Executive Leadership Additions

3D Systems Corporation (DDD), a leader in 3D printing and digital manufacturing solutions, has recently announced substantial organizational changes and the addition of new executive leadership to steer the company into a future filled with promising opportunities. These changes reflect the company's ongoing technical evolution and aim to harness the significant value creation potential presented by burgeoning regenerative medicine technologies.

New Executive Appointments

In a strategic move to strengthen its leadership team, DDD has welcomed Jeffrey Creech as the new Chief Financial Officer (CFO). Creech brings with him extensive experience in financial operations and strategy, promising to bolster the company's fiscal management and growth. Furthermore, Harriss T. Currie has been appointed as President of the Regenerative Medicine division, signaling a firm commitment to advancing this cutting-edge domain. His expertise and leadership are expected to drive innovation and success in the evolving medical sector.

Structural Reorganization for Innovation

The latest organizational revamp at DDD aligns with the company's focus on technological innovation and market leadership. By restructuring, 3D Systems aims to optimize its operations and lay a robust foundation for the development and commercialization of advanced regenerative medicine technologies. This forward-thinking approach underscores the company's readiness to capitalize on the technical progress it has achieved while gearing up for the breakthroughs that lie ahead.

Headquartered in Rock Hill, South Carolina, 3D Systems Corporation maintains a presence across the Americas, Europe, the Middle East, Africa, and Asia Pacific. With its recent strategic changes, DDD is poised to reinforce its position as a pioneering force in the 3D printing and digital manufacturing landscape.

leadership, innovation, regenerative